Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02360748 · ClinicalTrials.gov registry record · NA
A Plant Based High Protein Diet to Improve Nutritional Outcomes in Peritoneal Dialysis Patients
A NA study of End Stage Renal Disease and Malnutrition, sponsored by Ochsner Health System.
- Completed
- Registry status
- NA
- Development phase
- 8
- Enrollment target
- 2
- Study locations
NCT02360748: Completed NA study of End Stage Renal Disease and Malnutrition, sponsored by Ochsner Health System.
NCT02360748 is a NA study of End Stage Renal Disease and Malnutrition that has completed, run by Ochsner Health System. The registered enrollment target is 8 participants, below the 833-participant average among 86 other End Stage Renal Disease trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02360748, a NA study of End Stage Renal Disease and Malnutrition, has completed, sponsored by Ochsner Health System.
- COMPLETED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
- 2
- Study locations
Study Summary
The study proposes that addition of high protein plant based diet will improve serum albumin as well serum phosphate for patients with End Stage Renal Disease (ESRD) on Dialysis. Patient will be provided additional food items to help improve their nutritional status.
Primary Outcome
albumin will improve on high protein plant based diet; we will measure patients' baseline nutritional parameters which will include serum album; Calcium and phosphate levels and then follow the same parameters on the dietary intervention
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Plant based high protein food items
Study Locations (2)
Louisiana
- OCHSNER - Baton Rouge
- Davita - Baton Rouge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2015-10 |
| Est. Completion | 2017-09-15 |
| Phase | NA |
What the finished NCT02360748 record still lists
NCT02360748 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 833-participant average among 86 other End Stage Renal Disease trials with a reported enrollment target (99% lower).
The record links to 2 conditions, with End Stage Renal Disease appearing as the primary indexed condition, and to 1 intervention - of which Plant based high protein food items is the first listed.
NCT02360748 reports a single indexed study location in Louisiana.
Frequently Asked Questions
What is clinical trial NCT02360748 about?
NCT02360748 is a clinical study titled "A Plant Based High Protein Diet to Improve Nutritional Outcomes in Peritoneal Dialysis Patients". The study proposes that addition of high protein plant based diet will improve serum albumin as well serum phosphate for patients with End Stage Renal Disease (ESRD) on Dialysis. Patient will be provided additional food items to help improve their nutritional status.
What is the current status of trial NCT02360748?
This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2015-10. Estimated completion is 2017-09-15.
What conditions does trial NCT02360748 study?
This clinical trial studies the following conditions: End Stage Renal Disease, Malnutrition.
What interventions are being tested in trial NCT02360748?
The interventions under investigation include: Plant based high protein food items (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02360748?
This trial is sponsored by Ochsner Health System, which has 29 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02360748 being conducted?
This trial has 2 study locations across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for End Stage Renal Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02360748's enrollment target sits among peer trials
8 82nd of 86 higher than 4 of 86 other End Stage Renal Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other End Stage Renal Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study
RECRUITING · NA
-
Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial
RECRUITING · NA
-
Shared Decision Making for Kidney Transplant Candidates to Plan for an Organ Offer Decision
RECRUITING · NA
-
Blood Pressure Slopes and Ultrafiltration in Hemodialysis Patients
RECRUITING · NA
-
CAPABLE Transplant
RECRUITING · NA
-
Intravascular Ultrasound in Patients With End-stage Renal Disease on Dialysis
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia